Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sung, S.-Y.
Right arrow Articles by Chung, L. W.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sung, S.-Y.
Right arrow Articles by Chung, L. W.K.
[Cancer Research 66, 9519-9526, October 1, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Oxidative Stress Induces ADAM9 Protein Expression in Human Prostate Cancer Cells

Shian-Ying Sung1,2, Hiroyuki Kubo1,6, Katsumi Shigemura1, Rebecca S. Arnold4, Sanjay Logani4, Ruoxiang Wang1, Hiroyuki Konaka1, Masayuki Nakagawa6, Spiro Mousses7, Mahul Amin4, Cynthia Anderson2, Peter Johnstone2, John A. Petros1,4, Fray F. Marshall1, Haiyen E. Zhau1 and Leland W.K. Chung1,3,5

1 Molecular Urology and Therapeutics Program, Department of Urology, 2 Department of Radiation Oncology, 3 Winship Cancer Institute; Departments of 4 Pathology, 5 Biochemistry, and Hematology/Oncology, Emory University School of Medicine, Atlanta, Georgia; 6 Department of Urology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan; and 7 Translational Genomics Research Institute, Gaithersburg, Maryland

Requests for reprints: Shian-Ying Sung, Department of Urology, Emory University School of Medicine, Suite 5100, Room B5101, 1365B Clifton Road, Atlanta, GA 30322. Phone: 404-778-3663; Fax: 404-778-3675; E-mail: ssung2{at}emory.edu or Leland W.K. Chung, Molecular Urology and Therapeutics Program, Department of Urology, Emory University School of Medicine, Atlanta, GA 30322. Phone: 404-778-3672; E-mail: lwchung{at}emory.edu.

The ADAM (a disintegrin and metalloprotease) family is a group of transmembrane proteins containing cell adhesive and proteolytic functional domains. Microarray analysis detected elevated ADAM9 during the transition of human LNCaP prostate cancer cells from an androgen-dependent to an androgen-independent and metastatic state. Using a prostate tissue array (N = 200), the levels of ADAM9 protein expression were also elevated in malignant as compared with benign prostate tissues. ADAM9 protein expression was found in 43% of benign glands with light staining and 87% of malignant glands with increasing intensity of staining. We found that ADAM9 mRNA and protein expressions were elevated on exposure of human prostate cancer cells to stress conditions such as cell crowding, hypoxia, and hydrogen peroxide. We uncovered an ADAM9-like protein, which is predominantly induced together with the ADAM9 protein by a brief exposure of prostate cancer cells to hydrogen peroxide. Induction of ADAM9 protein in LNCaP or C4-2 cells can be completely abrogated by the administration of an antioxidant, ebselen, or genetic transfer of a hydrogen peroxide degradative enzyme, catalase, suggesting that reactive oxygen species (ROS) are a common mediator. The induction of ADAM9 by stress can be inhibited by both actinomycin D and cycloheximide through increased gene transcription and protein synthesis. In conclusion, intracellular ROS and/or hydrogen peroxide, generated by cell stress, regulate ADAM9 expression. ADAM9 could be responsible for supporting prostate cancer cell survival and progression. By decreasing ADAM9 expression, we observed apoptotic cell death in prostate cancer cells. (Cancer Res 2006; 66(19): 9519-26)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.